University of Chicago Innovation Fund Puts $100K in Genomic Prescribing System

The University of Chicago Innovation Fund, which invests in proof-of-concept and early business development work for new ventures created by University of Chicago faculty, students and staff, has awarded Mark Ratain, MD, and Peter O’Donnell, MD, $100,000 to support their work on the Genomic Prescribing System (GPS)

Portland State University’s DesignMedix Closes Second Angel Round of $1.5 Million

DesignMedix, Inc., a biotech startup with ties to Portland State University, has closed a second round of angel funding from investors in the Northwest. Investors include Portland Seed Fund, as well as members of Bellingham Angels, Oregon Angel Fund, Seraph Angel Network, Willamette Angel Conference, Keiretsu Angel Forum and Tacoma Angel Network.

Gillibrand wants to fill venture capital void

U.S. Sen. Kirsten Gillibrand wants to do for upstate New York what the venture capital sector has not. While New York state universities rake in $6 billion a year in government research funding — ranking it No. 2 in the country — the state and upstate New York in particular lag behind most of the country when it […]

Delaware Early Stage Venture Fund to Invest $50K-250K in Regional Start-ups

Leading Edge Ventures I, L.P., announced today the formation of an early stage venture fund. Headquartered in Newark, Delaware, the Fund will make investments in promising early stage companies in Delaware and the Mid- Atlantic region. It will also maintain an office in Bethlehem, PA. Leading Edge Ventures will target companies that provide productivity benefits […]

Governor Cuomo Announces $900,000 to Fund Biomedical Research Projects at Nine SUNY Campuses

Albany, NY – July 8, 2014 – Governor Andrew M. Cuomotoday announced $900,000 in funding for projects supported by the State University of New York Health Network of Excellence. This first round of funding will be awarded to six projects engaging students and faculty on nine SUNY campuses and their partners in the private sector to research causes, treatments […]